Axogen, Inc.
43.44USD
-3.8300 (-8.11%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.13▼ | $0.14 | 1 | 6 |
| Next quarter | $0.14▼ | $0.15 | 0 | 5 |
| Current year | $0.46▼ | $0.49 | 1 | 6 |
| Next year | $0.69▼ | $0.73 | 2 | 3 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.12 | $0.12 | +0.00 (+1.2%) |
| 2026-03-31 | $0.07 | $0.07 | -0.00 (-2.0%) |
| 2025-12-31 | $0.1 | $0.07 | -0.03 (-27.9%) |
| 2025-09-30 | $0.07 | $0.12 | +0.05 (+76.5%) |
71 ratings from 21 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Truist Securities | Initiated | Buy | $60 | Aug 26, 2026 |
| Canaccord Genuity | Maintained | Buy | $50 $55 | Jul 30, 2026 |
| Citizens | Maintained | Market Outperform | $50 $55 | Jul 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50 $53 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $45 $50 | Apr 29, 2026 |
| Citizens | Maintained | Market Outperform | $42 $50 | Apr 29, 2026 |
| Wells Fargo | Maintained | Overweight | $40 $48 | Apr 29, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $39 $50 | Apr 29, 2026 |
| Lake Street | Maintained | Buy | $40 $50 | Apr 23, 2026 |
| Canaccord Genuity | Maintained | Buy | $40 | Mar 30, 2026 |
| Citizens | Maintained | Market Outperform | $34 $42 | Feb 24, 2026 |
| Wells Fargo | Initiated | Overweight | $40 | Feb 19, 2026 |
| Canaccord Genuity | Maintained | Buy | $27 $37 | Dec 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $26 $39 | Dec 5, 2025 |
| Jefferies | Maintained | Buy | $29 $36 | Dec 4, 2025 |
| Lake Street | Maintained | Buy | $30 $40 | Dec 4, 2025 |
| Mizuho | Initiated | Outperform | $40 | Dec 1, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $25 $26 | Oct 30, 2025 |
| Raymond James | Maintained | Outperform | $20 $27 | Oct 30, 2025 |
| Canaccord Genuity | Maintained | Buy | $24 $27 | Oct 30, 2025 |
| Citizens | Maintained | Market Outperform | $26 $34 | Oct 30, 2025 |
| HC Wainwright & Co. | Initiated | Buy | $25 | Sep 30, 2025 |
| Canaccord Genuity | Maintained | Buy | $26 $24 | May 13, 2025 |
| Lake Street | Initiated | Buy | $30 | Mar 17, 2025 |
| Cantor Fitzgerald | Reiterated | Overweight | $24 | Mar 5, 2025 |
87 filings from 14 insiders · 15 buy / 11 sell over 6m
Officers and directors of AXGN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| TYNDALL JOSEPH ADirector | Sell | 3.5k | $49.70 | $174k | Sep 2, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Exercise | 13.4k | $14.85 | $198k | Aug 11, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Sell | 13.4k | $48.42 | $647k | Aug 11, 2026 |
| BEGAN MARC A.General Counsel | Exercise | 67.5k | $8.16 | $551k | Aug 10, 2026 |
| BEGAN MARC A.General Counsel | Sell | 67.5k | $47.34 | $3.20M | Aug 10, 2026 |
| WEILER KATHY JOHNSONDirector | Sell | 14.2k | $45.30 | $641k | Aug 7, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| THOMAS PAUL GDirector | Other | 18.9k | — | — | Jun 18, 2026 |
| WEILER KATHY JOHNSONDirector | Other | 14.2k | — | — | Jun 18, 2026 |
| TYNDALL JOSEPH ADirector | Other | 14.2k | — | — | Jun 18, 2026 |
| LEVINE ALAN M.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| BURKE WILLIAM P.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| JOHNSON JOHN H.Director | Other | 14.2k | — | — | Jun 18, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Exercise | 1.6k | $14.85 | $24k | May 8, 2026 |
| MCBRIDE-WENDELL AMY A.Director | Sell | 1.6k | $42.60 | $70k | May 8, 2026 |
| HARTLEY LINDSEY MARIEChief Financial Officer | Exercise | 5.5k | $8.20 | $45k | May 7, 2026 |
| WEILER KATHY JOHNSONDirector | Exercise | 16.3k | $6.95 | $114k | May 7, 2026 |
| JOHNSON JOHN H.Director | Exercise | 11.1k | $7.04 | $78k | May 7, 2026 |
| QUACKENBUSH DORISOfficer | Sell | 3.9k | $43.51 | $169k | May 7, 2026 |
| HARTLEY LINDSEY MARIEChief Financial Officer | Sell | 1.1k | $43.67 | $46k | May 7, 2026 |
No analyst notes on AXGN yet.
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 8 | 0 | 0 | 0 | Buy1.80 |
| 1 mo ago | 2 | 7 | 0 | 0 | 0 | Buy1.78 |